2.
Comprehensive Control of Human Papillomavirus Infections and Related Diseases
by Bosch, F. Xavier
Vaccine, 2013, Vol.31 (Suppl 7), p.H1-H31
3.
Human papillomavirus (HPV), HPV-associated oropharyngeal cancer, and HPV vaccine in the United States—Do we need a broader vaccine policy?
by Osazuwa-Peters, N
Vaccine, 2013, Vol.31 (47), p.5500-5505
4.
Human papillomavirus vaccine motivators and barriers among community college students: Considerations for development of a successful vaccination program
by Hirth, Jacqueline M
Vaccine, 2018-02-14, Vol.36 (8), p.1032-1037
5.
Therapeutic DNA Vaccines for Human Papillomavirus and Associated Diseases
by Cheng, Max A
Human gene therapy, 2018-09-01, Vol.29 (9), p.971-996
6.
P3.054 Identification of HPV Vaccine-Genotypes in a Female STI Population Group
by Hartl, N I
Sexually transmitted infections, 2013-07, Vol.89 (Suppl 1), p.A165-A165
7.
Therapy of Human Papillomavirus-Related Disease
by Stern, Peter L
Vaccine, 2012, Vol.30 (5), p.F71-F82
8.
Can a single dose of human papillomavirus (HPV) vaccine prevent cervical cancer? Early findings from an Indian study
by Sankaranarayanan, Rengaswamy
Vaccine, 2018-08-06, Vol.36 (32), p.4783-4791
9.
An update of prophylactic human papillomavirus L1 virus-like particle vaccine clinical trial results
by Schiller, John T
Vaccine, 2008, Vol.26 (Suppl 10), p.K53-K61
10.
O01.5 Efficacy of RG1-VLP Vaccination Against Genital and Cutaneous Human Papillomaviruses in Vitro and in Vivo
by Schellenbacher, C
Sexually transmitted infections, 2013-07, Vol.89 (Suppl 1), p.A27
11.
Human papillomavirus knowledge, attitudes, and vaccination among Chinese college students in the United States
by Tung, Wei-Chen
Vaccine, 2019-05-27, Vol.37 (24), p.3199-3204
12.
Comprehensive Control of Human Papillomavirus Infections and Related Diseases
by Bosch, F. Xavier
Vaccine, 2013, Vol.31 (Suppl 7), p.I1-I31
13.
14.
Minimal prevalence of HPV vaccination and common occurrence of high-risk HPV types in pregnant women with HIV: data from a national study in Italy
by Floridia, Marco
European journal of clinical microbiology & infectious diseases, 2022-01-09, Vol.41 (3), p.505-509
15.
Reduction in HPV 16/18 prevalence in sexually active young women following the introduction of HPV immunisation in England
by Mesher, D
Vaccine, 2013, Vol.32 (1), p.26-32
16.
Regional variations in human papillomavirus prevalence across time in NHANES (2003–2014)
by Hirth, Jacqueline M
Vaccine, 2019-07-09, Vol.37 (30), p.4040-4046
17.
Polymerase Chain Reaction Human Papillomavirus (HPV) Detection and HPV Genotyping in Invasive Cervical Cancers With Prior Negative HC2 Test Results
by Tao, Xiang
American journal of clinical pathology, 2017-05-01, Vol.147 (5), p.477-483
18.
Oral and laryngeal HPV infection: Incidence, prevalence and risk factors, with special regard to concurrent infection in head, neck and genitals
by Wierzbicka, Malgorzata
Vaccine, 2021-04-22, Vol.39 (17), p.2344-2350
19.
20.
Evidence for single-dose protection by the bivalent HPV vaccine—Review of the Costa Rica HPV vaccine trial and future research studies
by Kreimer, Aimée R
Vaccine, 2018-08-06, Vol.36 (32), p.4774-4782
